Literature DB >> 1894363

Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection.

D J Hayes1, C R Stubberfield, J D McBride, D L Wilson.   

Abstract

The rate of hydrolysis of three cysteine-type proteinase substrates, N-benzyloxycarbonyl-Arg-Arg-4-methyl-7-coumarylamide (AMC) (cathepsin B), Arg-AMC (cathepsin H), and N-benzyloxycarbonyl-Phe-Arg-AMC (cathepsin L), were determined in rat lung throughout the time course of the induction of Pneumocystis carinii infection by immunosuppression. Cathepsin B-like and cathepsin L-like activities fell below control values initially, but from week 8 of the immunosuppressive treatment significant increases above the control were noted. Cathepsin H-like activity was greater than control levels from week 3, and by week 12 it was 7,600% of the mean control value. When compared with the relative degree of infection, as assessed from the number of cysts present in lung impression smears, cathepsin B-like and cathepsin L-like activities were significantly increased only at heavy parasite burdens while cathepsin H-like activity displayed a close correlation with parasite number (r = 0.884; P less than 0.001). Activity was detected in lysates of purified P. carinii with all three substrates. Treatment of heavily infected animals with co-trimoxazole cleared the lungs of P. carinii, and this was accompanied by a marked reduction in proteinase activity, in particular, cathepsin H-like activity, which fell from 108- to 3-fold the mean control value following drug treatment. Analysis of cathepsin H isozyme patterns by fluorography following isoelectric focusing revealed differences between treated and control lung samples. In the immunosuppressed group, there was a time-dependent increase in the intensity of some of the bands observed in the controls and an appearance of several novel bands which corresponded to bands observed in lysates of P. carinii. It is likely, therefore, that the increased proteinase activity observed in the treated group is due, at least in part, to isozymes from P. carinii; consequently, cathepsin H-like activity might be of use diagnostically in the identification of P. carinii infection and in the estimation of parasite burden.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894363      PMCID: PMC258924          DOI: 10.1128/iai.59.10.3581-3588.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Comparison of proteolytic enzyme activity in pulmonary alveolar macrophages and blood leukocytes in smokers and nonsmokers.

Authors:  J O Harris; G N Olsen; J R Castle; A S Maloney
Journal:  Am Rev Respir Dis       Date:  1975-05

2.  Separation of Pneumocystis carinii from the lung of the steroid-suppressed rat.

Authors:  M B Taylor; C S Easmon
Journal:  FEMS Microbiol Lett       Date:  1990-06-15       Impact factor: 2.742

3.  Prevalence of Pneumocystis carinii pneumonitis in severe combined immunodeficiency.

Authors:  R J Leggiadro; J A Winkelstein; W T Hughes
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

Review 4.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Glycosidases and proteases of alveolar macrophages obtained by bronchoalveolar lavage from smokers and non-smokers.

Authors:  A Scharfman; J J Lafitte; A B Tonnel; C Aerts; B Sablonniere; P Roussel
Journal:  Lung       Date:  1980       Impact factor: 2.584

6.  Human cathepsin H.

Authors:  W N Schwartz; A J Barrett
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

7.  Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia.

Authors:  D J Winston; W K Lau; R P Gale; L S Young
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

8.  Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.

Authors:  P N Lanken; M Minda; G G Pietra; A P Fishman
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

9.  Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; V L Gray; W E Gutteridge; V S Latter; M Pudney
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

10.  Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; P C McNabb; T D Makres; S Feldman
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

View more
  1 in total

1.  Purification of a 68-kDa cysteine proteinase from crude extract of Pneumocystis carinii.

Authors:  M H Choi; B S Chung; Y B Chung; J R Yu; S R Cho; S T Hong
Journal:  Korean J Parasitol       Date:  2000-09       Impact factor: 1.341

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.